视网膜中央动脉阻塞

目的通过光化学法建立一个新的和临床病理机制相似的视网膜中央动脉阻塞（centralretinalarteryocclusion，CRAO）模型。

Objective To set up a new animal model of occlusion of central retinal artery ( CRAO ) which was quite similar to the clinical features .

目的观察重组葡激酶（recombinantstaphylokinase，r-Sak）治疗实验性视网膜中央动脉阻塞（centralretinalarteryocclusion，CRAO）的效果及其对全身的影响。

Objective To inspect the effects of recombinant staphylokinase ( r Sak ) and the changes of fibrinolytic activity in the systemic circulation in the treatment of experimental central retinal artery occlusion ( CRAO ) .

目的观察超选择性动脉插管溶栓治疗视网膜中央动脉阻塞（CRAO）的治疗效果。

Objective To evaluate the therapeutic effects of super-selective arterial catheterization with thrombolysis for central retinal artery occlusion ( CRAO ) .

溶栓治疗视网膜中央动脉阻塞病人的护理

Nursing care of central retinal artery occlusion patients undergoing thrombolytic therapy

经颈内动脉灌注溶栓药治疗实验性视网膜中央动脉阻塞

Thrombolytic drug infusion via carotid artery treating experimental central retinal artery occlusion

大剂量尿激酶冲击溶栓治疗视网膜中央动脉阻塞

Thrombolytic therapy of high dose urokinase impact for central retinal artery occlusion

视网膜中央动脉阻塞的荧光血管造影特征

Observation of the fundus fluorescein angiography of the central retinal artery occlusion

介入溶栓治疗视网膜中央动脉阻塞

Treatement of central retinal artery occlusion with by catheterizing thrombolysis

局部动脉内溶栓治疗视网膜中央动脉阻塞26例报告

Selective intra-arterial thrombolytic therapy for central retinal artery occlusion : 26 cases report

光化学法诱导家兔视网膜中央动脉阻塞

Photochemically induced occlusion of central retinal artery in rabbits

经眼动脉超选插管溶栓治疗视网膜中央动脉阻塞

Treatment of central retinal artery occlusion by thrombolysis via super-selective ophthalmic artery catheterization

选择性眼动脉溶栓治疗急性视网膜中央动脉阻塞

Local intra-arterial thrombolysis for acute central retinal artery occlusion

视网膜中央动脉阻塞的颈内动脉造影检查和介入溶栓治疗

Internal carotid artery angiography and interventional thrombolytic therapy for central retinal artery occlusion

视网膜中央动脉阻塞患者血液流变学分析

Hemorrheologic analyses of central retinal arteral occlusion

目的观察局部动脉内溶栓治疗视网膜中央动脉阻塞的疗效，探讨如何提高其治疗效果。

Objective To observe the effect of selective intra-arterial thrombolytic therapy for central retinal artery thrombosis .

重组葡激酶和尿激酶在治疗实验性视网膜中央动脉阻塞中的比较

Comparison of recombinant staphylokinase and urokinase in the treatment of experimental occlusion of the central retinal artery

1例系统性红斑狼疮患者视网膜中央动脉阻塞及脑出血的护理

Nursing Care for A Systemic Lupus Erythematosus Patient Complicated with Central Retinal Artery Occlusion and Cerebral Hemorrhage

超选择性眼动脉溶栓治疗视网膜中央动脉阻塞是安全、可靠的。

The method of thrombolysis via super - selective ophthalmic artery catheterization for CRVO is safe and reliable .

视网膜中央动脉阻塞，而使视网膜呈明显的灰白色并使血管萎陷。

Occlusion of the central retinal artery causes marked pallor of the retina and collapse of the vessels .

系统性红斑狼疮伴视网膜中央动脉阻塞和脑出血1例报告及文献复习

Systemic Lupus Erythematosus Complicated With Central Retinal Artery Occlusion and Cerebral Hemorrhage : a Case Report and Review of Literatures

结论：用电刺激小脑顶核治疗视网膜中央动脉阻塞是一种安全、有效的新方法。

Conclusion : It is a safe and effective method to use the electrical stimulation of CFN to treat the patients with CRAO .

结论视网膜中央动脉阻塞介入溶栓治疗可使大部分患者视力不同程度的提高。

Conclusions Thrombolysis via super-selective ophthalmic artery catheterization for CRAO can improve the visual acuity of most of the patients in different degrees .

临床上在治疗脑外伤、缺血性眼病、视网膜中央动脉阻塞等疾病，在改进老年患者的认知功能、防治偏头痛、改善脑卒中后自主神经紊乱等方面也有非常重要的临床应用前景。

It also can be applied to treat brain trauma , ischemic ophthalmopathy , central retinal artery occlusion , and hemicrania , and to improve cognition function , and to benefit for the treatment of autonomic nervous cardiovascular disturbances after cerebral ischemia etc.

超选择眼动脉插管溶栓治疗视网膜中央动脉不全阻塞1例体会

One case : superselective transcatheter thrombolysis for treatment of central retinal artery incomplete occlusion

视网膜中央动脉、静脉阻塞患者各发现一例。视网膜血管阻塞年龄分布以青年与老年较多，性别无差异。

The obstruction of retinal vessels was often found in the young and the aged people , without sexual difference .

结果：多数眼底疾病如视网膜中央动脉或静脉阻塞、糖尿病性视网膜病变、视网膜血管炎、视网膜血管瘤及脉络膜血管瘤等的血流速度表现异常，多数动脉和静脉血流速度不同程度下降。

Velocity of blood flow in artery and vein showed decreased in most of fundus diseases such as central retinal artery or vein occlusion , diabetic retinopathy , etc.